Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Oct 20;7(10):147.
doi: 10.3390/antiox7100147.

Cytoprotective Effects of Natural Compounds against Oxidative Stress

Affiliations
Review

Cytoprotective Effects of Natural Compounds against Oxidative Stress

Jay Mehta et al. Antioxidants (Basel). .

Abstract

Oxidative stress, an imbalance between reactive oxygen species and antioxidants, has been witnessed in pathophysiological states of many disorders. Compounds identified from natural sources have long been recognized to ameliorate oxidative stress due to their inherent antioxidant activities. Here, we summarize the cytoprotective effects and mechanisms of natural or naturally derived synthetic compounds against oxidative stress. These compounds include: caffeic acid phenethyl ester (CAPE) found in honey bee propolis, curcumin from turmeric roots, resveratrol abundant in grape, and 1-[2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oyl] imidazole (CDDO-Im), a synthetic triterpenoid based on naturally occurring oleanolic acid. Cytoprotective effects of these compounds in diseases conditions like cardiovascular diseases and obesity to decrease oxidative stress are discussed.

Keywords: CAPE; CDDO-Im; cardiovascular diseases; curcumin; cytoprotection; obesity; oxidative stress; resveratrol.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Structures of CAPE (caffeic acid phenethyl ester), Curcumin, Resveratrol, and CDDO-Im (1-[2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oyl] imidazole).
Figure 2
Figure 2
Mechanism of action of resveratrol to reduce inflammation, oxidative stress and obesity. AMPK: AMP-activated protein kinase; ERK: extracellular signal-regulated kinase; NF-κB: nuclear factor - kappa B; Nrf2: nuclear erythroid 2 - related factor; SIRT1: sirtuin 1.
Figure 3
Figure 3
Overview of the cytoprotective mechanisms of CAPE, CDDO-Im, curcumin and resveratrol. All the four compounds inhibit NFκB [12,26,46,59] and trigger Nrf2 nuclear translocation to activate HO-1 expression. Induction of HO-1 by curcumin and CDDO-Im is mediated in part through the activation of MAPK signaling which in turn translocates Nrf2 [59]. The cytoprotective mechanism of resveratrol and CAPE include Nrf2-medaited HO-1 induction coupled with the activation of ERK signaling pathway [34,142]. CAPE: caffeic acid phenethyl ester; CDDO-Im: 1-[2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oyl] imidazole; ERK: extracellular signal-regulated kinase; GPx: glutathione peroxidase; HO-1: heme oxygenase-1; MAPK: mitogen-activated protein kinase; NF-κB: nuclear factor - kappa B; Nrf2: nuclear erythroid 2 - related factor; PI3K/Akt: phosphatidylinositol 3-kinase/ protein kinase B; SOD: superoxide dismutase.

Similar articles

Cited by

References

    1. Ma Q. Transcriptional responses to oxidative stress: Pathological and toxicological implications. Pharmacol. Ther. 2010;125:376–393. doi: 10.1016/j.pharmthera.2009.11.004. - DOI - PubMed
    1. Sugamura K., Keaney J.F., Jr. Reactive oxygen species in cardiovascular disease. Free Radic. Biol. Med. 2011;51:978–992. doi: 10.1016/j.freeradbiomed.2011.05.004. - DOI - PMC - PubMed
    1. Betteridge D.J. What is oxidative stress? Metab. Clin. Exp. 2000;49:3–8. doi: 10.1016/S0026-0495(00)80077-3. - DOI - PubMed
    1. Kohen R., Nyska A. Oxidation of biological systems: Oxidative stress phenomena, antioxidants, redox reactions, and methods for their quantification. Toxicol. Pathol. 2002;30:620–650. doi: 10.1080/01926230290166724. - DOI - PubMed
    1. Zhao B. Natural antioxidants protect neurons in Alzheimer’s disease and Parkinson’s disease. Neurochem. Res. 2009;34:630–638. doi: 10.1007/s11064-008-9900-9. - DOI - PubMed

LinkOut - more resources